Page last updated: 2024-08-21

indazoles and Lymphoma

indazoles has been researched along with Lymphoma in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Albakova, Z; Mangasarova, Y; Sapozhnikov, A1
Alarcon, SV; Brega, N; Crandon, S; Figg, WD; Giaccone, G; Gutierrez, M; Houk, BE; Jain, L; Kelly, RJ; Kim, YS; Kummar, S; Mannargudi, B; Rajan, A; Shnaidman, M; Trepel, JB; Zein, WM1
Allain, CJ; Chesworth, R; Copeland, RA; Jin, L; Keilhack, H; Klaus, CR; Knutson, SK; Kuntz, KW; Majer, CR; Moyer, MP; Olhava, EJ; Pollock, RM; Raimondi, A; Richon, VM; Sacks, JD; Scott, MP; Smith, JJ; Sneeringer, CJ; Song, J; Warholic, NM; Wigle, TJ1
Gondo, H; Harada, M; Matsuishi, H; Omori, F; Otsuka, T; Shibuya, T; Taniguchi, S; Teshima, T; Yamano, Y; Yamazaki, K1
Cohen, JD; Lagoni, R; Longo, WL; Neville, AJ; O'Keefe, S; Riggs, C; Robins, HI; Schmitt, CL; Steeves, RA1
Covelli, A; De Fabritiis, P; De Felice, L; Mandelli, F; Pulsoni, A; Sandrelli, A; Simone, F; Zupi, G1
Clive, D1

Reviews

1 review(s) available for indazoles and Lymphoma

ArticleYear
Heat Shock Proteins in Lymphoma Immunotherapy.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Animals; Benzamides; Benzodioxoles; Glycine; Heat-Shock Proteins; Humans; Immunotherapy; Immunotherapy, Adoptive; Indazoles; Isoxazoles; Lymphoma; Molecular Targeted Therapy; Purines; Resorcinols

2021

Trials

3 trial(s) available for indazoles and Lymphoma

ArticleYear
A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Nov-01, Volume: 17, Issue:21

    Topics: Adult; Aged; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glycine; HSP90 Heat-Shock Proteins; Humans; Indazoles; Lymphoma; Male; Middle Aged; Neoplasms

2011
[Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:10

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Granisetron; Humans; Indazoles; Lymphoma; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting

1993
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations.
    International journal of radiation oncology, biology, physics, 1990, Volume: 18, Issue:4

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Cell Line; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; In Vitro Techniques; Indazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Mice; Mice, Inbred AKR; Middle Aged; Pilot Projects; Pyrazoles; Whole-Body Irradiation

1990

Other Studies

3 other study(ies) available for indazoles and Lymphoma

ArticleYear
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.
    Nature chemical biology, 2012, Volume: 8, Issue:11

    Topics: Antineoplastic Agents; Cell Cycle; Cell Death; Cell Proliferation; Dose-Response Relationship, Drug; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Histones; Humans; Indazoles; Lymphoma; Lysine; Methylation; Molecular Structure; Point Mutation; Polycomb Repressive Complex 2; Pyridones; Structure-Activity Relationship

2012
In vitro pharmacological purging of human bone marrow is enhanced by the use of lonidamine.
    Experimental and molecular pathology, 1989, Volume: 50, Issue:2

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Marrow; Cell Line; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Indazoles; Lymphoma; Neoplastic Stem Cells; Pyrazoles

1989
Recent developments with the L5178Y TK heterozygote mutagen assay system.
    Environmental health perspectives, 1973, Volume: 6

    Topics: Alkylating Agents; Animals; Cell Line; Cell Membrane Permeability; Cells, Cultured; Dose-Response Relationship, Drug; Ethane; Ethylenediamines; Genetic Techniques; Heterozygote; Hydrocarbons, Brominated; Indazoles; Lucanthone; Lymphoma; Mesylates; Methanol; Mice; Mutagens; Mutation; Radiation Effects; Thioxanthenes; Thymidine Kinase

1973